Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 41

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 41
---
 restricted stock/units outstanding(1)  | ​ | ​ | ​                              | ​ | 492,956 | ​ | ​ | ​ | ​                            | $ |      — | ​ | ​ | ​ | ​                   | ​ |    — | ​ | ​ |
| Total number of options outstanding(2)                 | ​ | ​ | ​                              | ​ | 708,779 | ​ | ​ | ​ | ​                            | $ | 231.19 | ​ | ​ | ​ | ​                   | ​ | 4.95 | ​ | ​ |
| Total number of performance share units outstanding(3) | ​ | ​ | ​                              | ​ | 293,853 | ​ | ​ | ​ | ​                            | $ |      — | ​ | ​ | ​ | ​                   | ​ |    — | ​ | ​ |

(1) For purposes of this table, only unvested restricted stock units as of December 28, 2024 are included. This number does not incorporate the 2.3 fungible ratio. (2) For purposes of this table, only options outstanding as of December 28, 2024 are included. (3) For purposes of this table, reflects currently projected potential maximum payouts of outstanding 2023 PSUs and target payouts of outstanding 2024 PSUs, taking into account the impact of non-GAAP EPS performance on both grants. This number does not incorporate the 2.3 fungible ratio.

35

DELINQUENT SECTION 16(a) REPORTS Section 16(a) of the Securities Exchange Act of 1934 requires our directors and officers, and persons who own more than 10% of our common stock, to file with the SEC initial reports of beneficial ownership and reports of changes in beneficial ownership of our common stock and other equity securities. Officers, directors, and such beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file. To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended December 28, 2024, our officers, directors, and such beneficial owners complied with all applicable Section 16(a) filing requirements, except that, on November 12, 2024, a Form 4 for Mr. Wallman reporting a gift of 4,540 shares was filed late due to an administrative oversight. PROPOSAL TWO—AD